Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2018
Heidelberg Pharma AG today announced that its collaboration partners MD Anderson Cancer Center, Houston, TX, USA, and Magenta Therapeutics, Cambridge, MA, USA, will present preclinical data at the 60th Annual Meeting of the American Society of Hematology (ASH), the leading convention for hematology. The meeting will take place from 1 to 4 December 2018 in San Diego, USA.